National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPROspective Renal Cancer Cohort Foundation
About this trial
PRO-RCC is a nationwide long-term cohort for the collection of real-world clinical data, patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) that provides an infrastructure for observational research and (randomized) interventional studies with the TwiCs (Trial within cohorts) design.
Eligibility criteria
Qualifiers
newly diagnosed patients with RCC or synchronous metastatic RCC
metachronous metastasized RCC
age >18 years
capable of understanding Dutch language
Disqualifiers
n/a
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 2 trial groupsLocations
27Amsterdam UMC locatie VUMC AmsterdamNorth Holland, Netherlands
Jeroen Bosch Ziekenhuis 's-Hertogenbosch Netherlands
Jeroen Bosch Ziekenhuis 's-Hertogenbosch Netherlands
Meander Medisch Centrum Amersfoort Netherlands
Sponsors and collaborators
PROspective Renal Cancer Cohort Foundation
Lead sponsor
Comprehensive Cancer Centre The Netherlands
Collaborator
Merck Sharp & Dohme LLC
Collaborator
Bristol-Myers Squibb
Collaborator
Ipsen
Collaborator
Pfizer
Collaborator
Source ClinicalTrials.gov